A policy and decision-making framework for South African doctors during the COVID-19 pandemic by Jones-Bonofiglio, K & Nortjé, N
IN PRACTICE
613       July 2020, Vol. 110, No. 7
Doctors are among the heroes who are leading critical changes to 
practices and procedures during the novel coronavirus SARS-CoV-2 
pandemic that had led to over 250 000 deaths worldwide as of 7 May 
2020.[1] However, there are many common constraints to adopting 
new behaviours and creating rapid changes in contemporary 
healthcare environments, such as healthcare workers’ knowledge, 
attitudes and beliefs, heavy clinical workloads, resource constraints 
and poor communication.[2] These everyday barriers set the stage 
for compounding the challenges of a global pandemic in healthcare 
systems that were already stressed and strained. In South Africa 
(SA), a pragmatic decision-making framework with a local context 
is needed that builds capacity to: (i) address healthcare workers’ 
needs; (ii) assist with allocation of scarce resources; and (iii) facilitate 
communication among key stakeholders in clinical practice. The 
authors of this article therefore wish to present an ethically justified 
framework on how to address a potential surge of clinical demands 
that can be used by doctors, in both the public and private healthcare 
sectors, to respond to difficult ethical decisions and choices.
The SA healthcare context
The SA healthcare system is socialised, and 84% of the population is 
serviced in the public health system by 30% of doctors, as opposed 
to 16% of the population that is served by 70% of the doctors 
in the private healthcare system.[3] It is has been shown that the 
annual per capita expenditure on healthcare ranges from ZAR2 520/
USD140 (public) to ZAR25 200/USD1 400 (private), indicating 
a large disparity in healthcare delivery and costs.[4] This disparity 
is largely due to a state of crisis of public hospitals related to run-
down and dysfunctional infrastructure because of underfunding, 
mismanagement and neglect.[3,5] Furthermore, this disparity also 
influences disease burden and effective treatment options, with the 
public health sector having fewer resources.[6]
The dire conditions of healthcare in SA are worrisome, and 
these vulnerabilities will be greatly exacerbated during the spread 
of COVID-19. Research indicates that individuals most susceptible 
to complications are those with underlying health conditions and 
comorbidities (e.g. hypertension, diabetes, heart disease) prior to 
contracting the virus.[7] As reported in news from abroad, many 
of these patients end up in intensive care units (ICUs) requiring 
ventilation. In a recent study, Mahomed et al.[8] found that ICUs in 
both the private and public sectors in SA do not meet international 
standards, with a huge shortage of mechanical ventilators (especially 
in the public health sector). Furthermore, in order to curb the spread 
of COVID-19, those who test positive need to be treated in isolated 
rooms. The authors of the ICU study report that the identified 10% 
of ICU beds that should be allocated as isolation rooms was not 
attained.[8] The aforementioned is problematic given the transmission 
and infection rates of the virus through droplet and direct contact,[9,10] 
as well as the projected number of people needing ventilator support 
and isolation.
SA as a country has faced heavy epidemic illness burdens previously, 
and lessons from these experiences (phronesis) can inform the next 
steps in the fight against COVID-19. SA doctors are in a unique 
position to respond, owing to past crisis and epidemic experiences 
with healthcare service delivery and prevention strategies, such as 
related to HIV-AIDS,[11] tuberculosis (TB), including multidrug-
resistant TB and extensively drug-resistant TB,[12-14] influenza[15,16] and 
Ebola.[17,18] Dealing with such outbreaks requires moral competence, 
clinical expertise, and administrative, political and legal navigation 
strategies to determine the next steps for ethical decisions in 
clinical practice. According to Lai et al.,[9] COVID-19 is the sixth 
international public health emergency since Ebola (2019; 2014), Zika 
(2016), polio (2014) and H1N1 (2009).[9]
The common message from Western media is that we all need 
to work together during this global crisis. SA has long held the 
philosophy, ideology and core values of collective solidarity and 
interdependence in the moral response of ubuntu.[19] As the basis of 
the SA Constitution, this shared cultural value represents a unique 
strength to draw on when addressing factors such as potential spread, 
community attitudes, and access to healthcare and scarce resources.
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Policy for ethical decision-making
Given that the virus is not contained in any specific locale and has 
already crossed borders and oceans, it is recommended that the 
global community unite in order to ‘flatten the curve’ of COVID-19. 
The basis of the proposed framework is set out in three phases, with 
key indicators, strategies and decisions (Fig. 1). This framework is 
meant to encourage engagement and ongoing communication with 
hospital administrators, infectious disease specialists and provincial 
governments, to determine how best to respond to the pandemic in 
their own local context with a transparent and ethically defensible 
approach.
Phase 1
The primary phase is activated early in the crisis stage of the 
pandemic where <2% of the local population exhibit key symptoms 
of COVID-19 (e.g. fever, cough, upper airway congestion, myalgia 
and headache)[20] and test positive. As data suggest, ~12% of positive 
patients may need to be intubated.[21] During this period, regular 
medical procedures and other services may continue, including 
scheduled and emergency surgery. In anticipation of what may 
transpire, it is recommended to conserve blood. Usual resuscitation 
(e.g. cardiopulmonary resuscitation (CPR), intubation, etc.) policy 
guidelines should be followed. Benefits and risks should be communi-
cated to patients and families during phase 1 to ascertain what is in 
the best interests of the patient.
In collaboration with doctors, hospital administration should 
reduce the hospital’s inpatient population as much as possible. This 
means discharging patients home if this is deemed to be a safer 
environment to recover in. It is also recommended during this phase 
that visitor limitations be implemented, only one visitor per patient 
being allowed, given the fact that community spread of the infection 
is one of the biggest drivers of this pandemic. Non-essential hospital 
services should be decanted by discharging patients to another 
facility or transition to home care.
During this phase it is assumed that there are still enough supplies 
and appropriate space to treat and care for patients, and enough 
qualified healthcare workers. Given the global scarcity of personal 
protective equipment (PPE), it is recommended that institutions 
create a stewardship effort to preserve this limited resource. The 
hospital’s administration should identify isolation units, prepare 
infrastructure, and plan access to these units.
Furthermore, administration needs to activate the formation of an 
ad hoc committee (committee for scarce resources), the aim of which 
is to manage scarce resource demands. The committee should begin 
by identifying resources that are likely to become scarce, develop a 
simple system for tracking the resources, and establish indicators for 
when to allocate specific resources. Ideally, this committee should 
consist of individuals with leadership experience and expertise in 
areas such as critical care, palliative care, infection control, public 
health, supply chain management, administration and ethics. Should 
people with such expertise not be readily available on site, sourcing 
them from regional academic institutions is recommended. Also, 
ensuring a multidisciplinary team approach to crisis management 
would potentially circumvent any biased oversight.
Phase 2
This level is activated when between 2% and 10% of the local 
population exhibit symptoms and test positive. All COVID-19-
positive patients should be moved to the isolation floor(s), and a 
no-visitor policy should be strictly enforced. Regarding CPR and 
intubation, the recommendation is to proceed with normal protocols, 
provided enough PPE is available. Patient resuscitation should 
not be attempted without appropriate donning of PPE. It is also 
recommended that all elective surgery be suspended, as operating 
rooms can also be used as isolation rooms. Only emergency surgery 
should be performed.
According to international trends, 20 - 30% of staff would be 
absent and space and supplies would be at capacity. Only essential 
workers should be allowed into the hospital, and all used PPE should 
be repurposed if it is safe to do. Unfortunately at this time difficult 
decisions will arise, and those patients with the best chance clinically 
for long-term survival outside the ICU should receive preference in 
the allocation of critical resources.
It is recommended that no single individual makes these decisions; 
rather, a second ad hoc committee should be created to navigate 
clinical decision-making (committee for clinical decision-making). 
Indicators
• Few reported cases (<2%), enough 
 space and resources
Strategies
• Conserve blood, maximise bed capacity, 
 decant services
• Ad hoc committee for scarce resource
  demands
Decisions
• Who will be discharged home?
• Which services will be on hold?
• Further, how to initiate:
  PPE stewardship eort
  preparation of isolation units
  activation of ad hoc committee to 
     respond to scarce resource demands
Indicators
• Some reported cases (>2 - 10%), 
 space and resources at capacity
Strategies 
• Conserve use of limited healthcare sta, 
 perform emergency surgeries only, 
 initiate isolation oor(s), enforce 
 'no visitors' policy, allow essential 
 workers only into hospital, repurpose 
 PPE when possible
• Ad hoc committee for clinical decisions
Decisions
• Who will receive critical/intensive 
 care services?
• Who will receive resuscitation?
• How to initiate activation of ad hoc
 clinical decisions committee?
Indicators
• Many reported cases (>10%), space 
 and resources critically limited
Strategies
• Withdrawal of life support measures 
 and limit resuscitations for patients
• Committees lead hospital's decision-
 making on utilisation of all resources 
 and patient care options
Decisions
• Who will be removed from receiving 
 critical care?
• Who will not be resuscitated?
• How to support physicians to respond 
 eciently and eectively to direct 
 clinical decisions in practice?
Phronesis: South African doctors' past and present knowledge, culture and experiences
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Fig. 1. Decision-making framework. (PPE = personal protective equipment.)
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In the public sector it would be recommended that some members 
of the first ad hoc committee (for allocating scarce resources) make 
up the clinical decisions committee. This second committee is meant 
to directly advise clinicians, in real time, concerning difficult ethical 
decisions in complex clinical patient care situations. It cannot be 
stressed sufficiently that decisions should be guided only by clinically 
relevant criteria as determined by the doctor’s assessment of the 
patient,[22] and no other bias (i.e. age, gender, ethnicity, legal status, 
sexual orientation) should be included in the evaluation.
Phase 3
The final phase is reached when >10% of the local population exhibits 
symptoms of infection and have tested positive. At this stage supplies, 
space and personnel are at critical levels and staff absenteeism 
of >30% will occur. The previously mentioned committees for 
resource allocation and clinical decision-making should be leading 
the hospital’s efforts in managing the pandemic and demands on the 
system. Given the dire situation and anticipated strain on ventilators 
and other supplies (e.g. medication for sedation to ensure comfort 
during intubation), withdrawing life-supporting interventions would 
be allowed if a patient shows no improvement. These decisions 
should again be made not by an individual but by a committee. If 
the demand outstrips the supply for treatment, it would be up to 
the committee to decide to limit treatment to patients with the most 
potential for long-term survival outside the ICU and those who 
have no comorbidities. Should a COVID-19-positive patient require 
resuscitation, the fewest people necessary should attend, and only if 
they have the necessary PPE. If there are competing needs, the usual 
triage guidelines should be followed, where saving patients with the 
most potential survival years should be prioritised.
Conclusions
None of the above ethical decisions in clinical practice will be easy 
to make. Further guidance for these issues can be found in the work 
of Hans Jonas, The Imperative of Responsibility.[23] He argues that any 
stakeholder is responsible to act in good faith and contribute to the 
enhancement of the system, as responsibility transcends the needs of 
an individual as well as the present time frame.[23] Therefore, in order 
for society to exist beyond this catastrophe, the present stakeholders 
need to work together collectively. This is the essence of ubuntu.[19]
Moreover, support for doctors’ decision-making in such a time 
of crisis is not only critical for patients, it is also critical for doctors 
themselves. Kotalik[24] highlights the risks of conflicting duties for 
doctors during a pandemic (e.g. patient as a victim and a potential 
vector, altered doctors’s responsibilities, role as agent of the law/
public health) and the risks for compromising one’s loyalties and 
integrity.[24] Doctors will have to make difficult choices, despite 
fear and many unknowns.[25] Even before this crisis, the health and 
wellbeing (e.g. physical, mental and spiritual) of doctors was at 
risk in everyday practice.[26,27] Supporting transparent and ethically 
defensible decision-making during this time of crisis will reduce 
the impact of burnout,[28] moral distress,[29] and the potential for 
doctors leaving (the country, medicine itself)[30] in the wake of the 
pandemic.
Doctors are a critically important resource for SA and her people. 
SA doctors have the knowledge, culture and experience to navigate 
this crisis, even in resource-poor settings. While is it fully recognised 
that ‘“doing more with less” is unfeasible’ (Brooke-Sumner et al.,[2] 
p.  137), this framework offers pragmatic indicators, strategies and 
key decisions to guide energies and efforts for pandemic management 
and in the recovery phase thereafter. It offers an opportunity to work 
together to bolster skills, maintain and maximise capacity, and draw 
on supportive relationships.
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